Insider Selling: LHC Group, Inc. (LHCG) Director Sells 12,000 Shares of Stock

LHC Group, Inc. (NASDAQ:LHCG) Director Ronald T. Nixon sold 12,000 shares of the company’s stock in a transaction on Wednesday, May 22nd. The stock was sold at an average price of $117.20, for a total value of $1,406,400.00. Following the sale, the director now owns 29,100 shares of the company’s stock, valued at $3,410,520. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Shares of LHCG opened at $114.49 on Friday. LHC Group, Inc. has a 52 week low of $74.00 and a 52 week high of $122.20. The firm has a market capitalization of $3.61 billion, a PE ratio of 32.25, a PEG ratio of 2.02 and a beta of 0.87. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.57 and a quick ratio of 1.57.

LHC Group (NASDAQ:LHCG) last announced its quarterly earnings results on Wednesday, May 8th. The health services provider reported $0.98 EPS for the quarter, beating the Zacks’ consensus estimate of $0.90 by $0.08. LHC Group had a return on equity of 8.43% and a net margin of 3.83%. The company had revenue of $502.59 million during the quarter, compared to analysts’ expectations of $511.16 million. As a group, analysts expect that LHC Group, Inc. will post 4.3 EPS for the current year.

Several equities research analysts have weighed in on LHCG shares. Zacks Investment Research cut LHC Group from a “buy” rating to a “hold” rating in a research note on Wednesday, April 10th. SunTrust Banks upped their target price on LHC Group to $130.00 and gave the stock a “buy” rating in a research note on Friday, March 1st. Robert W. Baird upped their target price on LHC Group from $98.00 to $120.00 and gave the stock a “neutral” rating in a research note on Monday, March 4th. Craig Hallum upped their target price on LHC Group from $93.00 to $114.00 and gave the stock a “hold” rating in a research note on Friday, March 1st. They noted that the move was a valuation call. Finally, Jefferies Financial Group upped their target price on LHC Group from $125.00 to $130.00 and gave the stock a “buy” rating in a research note on Thursday, May 9th. Four analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the stock. LHC Group has a consensus rating of “Buy” and a consensus target price of $118.50.

Several institutional investors and hedge funds have recently made changes to their positions in the company. Freestone Capital Holdings LLC lifted its stake in shares of LHC Group by 2.5% in the 1st quarter. Freestone Capital Holdings LLC now owns 4,181 shares of the health services provider’s stock valued at $464,000 after acquiring an additional 101 shares during the last quarter. Arizona State Retirement System lifted its stake in shares of LHC Group by 0.3% in the 1st quarter. Arizona State Retirement System now owns 45,057 shares of the health services provider’s stock valued at $4,995,000 after acquiring an additional 123 shares during the last quarter. State of Alaska Department of Revenue lifted its stake in shares of LHC Group by 1.6% in the 4th quarter. State of Alaska Department of Revenue now owns 9,775 shares of the health services provider’s stock valued at $917,000 after acquiring an additional 150 shares during the last quarter. Campbell Newman Asset Management Inc. raised its position in LHC Group by 2.4% during the 1st quarter. Campbell Newman Asset Management Inc. now owns 6,350 shares of the health services provider’s stock worth $704,000 after purchasing an additional 151 shares during the last quarter. Finally, BRYN MAWR TRUST Co raised its position in LHC Group by 0.3% during the 4th quarter. BRYN MAWR TRUST Co now owns 48,182 shares of the health services provider’s stock worth $4,523,000 after purchasing an additional 159 shares during the last quarter. Institutional investors own 93.88% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This story was first published by Baseball Daily News and is owned by of Baseball Daily News. If you are reading this story on another site, it was illegally copied and reposted in violation of U.S. & international copyright law. The correct version of this story can be read at https://www.baseballdailydigest.com/news/2019/05/25/insider-selling-lhc-group-inc-lhcg-director-sells-12000-shares-of-stock.html.

LHC Group Company Profile

LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.

Read More: Support Level

Insider Buying and Selling by Quarter for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.